Liu Ming, Wang Guan, Wang Lin, Wang Yuqi, Bian Yuqing, Shi Hang, Liu Jie
Department of Anesthesia, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Department of Dermatology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Front Med (Lausanne). 2023 Jan 4;9:1100756. doi: 10.3389/fmed.2022.1100756. eCollection 2022.
Neutrophil plays a more and more important role in sepsis with paralysis of immunoregulation. Till now, there was no biomarker to identify and isolate the mature and immature neutrophils in sepsis patients. CD10 shows on mature neutrophils at the latest stages of its differentiation. Our study aimed to investigate whether CD10 was a valid biomarker for distinguishing immature and mature neutrophil subgroups under septic conditions and their immunoregulatory effects on lymphocytes.
Totally 80 healthy volunteers and 107 sepsis patients were recruited in this study. Fluorescence-conjugated anti-CD66b, and anti-CD10 monoclonal antibodies followed by incubation with specific anti-fluorochrome microbeads was used to isolate different subgroups of neutrophils. T cell apoptotic assays and T cell proliferation assays followed by flow cytometry analysis were used to evaluate the immunoregulatory effect of each subgroup of neutrophils.
(1) The cytological morphology of CD10 neutrophils was mature and that of CD10 neutrophils was immature in sepsis patients. (2) Mature CD10 neutrophils inhibited the proliferation of T cell and immature CD10 neutrophils promoted the T cell proliferation.
(1) CD10 was a good biomarker to distinguish mature from immature neutrophils in sepsis patients. (2) Mature CD10 and immature CD10 neutrophils displayed opposite immunoregulatory effects on T cells in sepsis patients.
中性粒细胞在免疫调节麻痹的脓毒症中发挥着越来越重要的作用。到目前为止,尚无生物标志物可用于识别和分离脓毒症患者中的成熟和未成熟中性粒细胞。CD10在成熟中性粒细胞分化的最后阶段表达。本研究旨在探讨CD10是否是脓毒症条件下区分未成熟和成熟中性粒细胞亚群的有效生物标志物及其对淋巴细胞的免疫调节作用。
本研究共招募了80名健康志愿者和107名脓毒症患者。使用荧光偶联的抗CD66b和抗CD10单克隆抗体,然后与特异性抗荧光染料微珠孵育,以分离中性粒细胞的不同亚群。采用T细胞凋亡检测和T细胞增殖检测,随后进行流式细胞术分析,以评估各中性粒细胞亚群的免疫调节作用。
(1)脓毒症患者中,CD10⁺中性粒细胞的细胞学形态成熟,CD10⁻中性粒细胞的细胞学形态未成熟。(2)成熟的CD10⁺中性粒细胞抑制T细胞增殖,未成熟的CD10⁻中性粒细胞促进T细胞增殖。
(1)CD10是区分脓毒症患者成熟与未成熟中性粒细胞的良好生物标志物。(2)成熟的CD10⁺和未成熟的CD10⁻中性粒细胞对脓毒症患者的T细胞表现出相反的免疫调节作用。